A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond
暂无分享，去创建一个
N. Arber | J. Stebbing | S. Tsiodras | S. Lev-Ari | Guy Choshen | S. Shapira | M. Peer | D. Kazanov | L. Bannon | M. B. Shimon | Jonathan Seni | Mori Hay-Levi | Gil Shenberg | Michael Tepper | Dimitrios Boubas | G. Shenberg | Gil Shenberg